Psomagen Inc Shs Korean Depositary Receipt Repr 1 Sh

Psomagen Inc Shs Korean Depositary Receipt Repr 1 Sh

KKRX:950200
2,610.00
KRW
-40.00
(-1.51%)
-91.27EPS
26.36P/E
53.86BMarket Cap

Total Valuation

KRW

As of June 30, 2026, Psomagen Inc Shs Korean Depositary Receipt Repr 1 Sh carries a market capitalization of 53.86B, placing it among publicly traded companies globally. Its enterprise value stands at 47.31B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap53.86B
Enterprise Value47.31B

Share Statistics

As of June 30, 2026, Psomagen Inc Shs Korean Depositary Receipt Repr 1 Sh has 19.24M shares outstanding.

Shares Outstanding19.24M

Valuation Ratios

As of June 30, 2026, Psomagen Inc Shs Korean Depositary Receipt Repr 1 Sh trades at a trailing price-to-earnings ratio of 26.36. The price-to-sales ratio is 0.97, and the price-to-book ratio stands at 1.69.

PE Ratio26.36
PS Ratio0.97
PB Ratio1.69
P/TBV Ratio2.02

Enterprise Valuation

As of June 30, 2026, Psomagen Inc Shs Korean Depositary Receipt Repr 1 Sh trades at an EV/EBITDA multiple of 15.30 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.83 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 47.31B versus a market cap of 53.86B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales0.83
EV / EBITDA15.30

Financial Position

As of June 30, 2026, Psomagen Inc Shs Korean Depositary Receipt Repr 1 Sh maintains a current ratio of 2.45, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities.

Current Ratio2.45
Quick Ratio1.30
Debt / Equity30.81
Debt / EBITDA3.18

Financial Efficiency

KRW

Over the twelve months ended June 30, 2026, Psomagen Inc Shs Korean Depositary Receipt Repr 1 Sh posted a return on equity (ROE) of 7.25, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 4.08, measuring how efficiently the asset base is converted into earnings. The company generates approximately 641.89M in revenue per employee across its workforce of 89.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 6.63 indicates how many times Psomagen Inc Shs Korean Depositary Receipt Repr 1 Sh sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)7.25
Return on Assets (ROA)4.08
Revenue Per Employee641.89M
Employee Count89.25
Inventory Turnover6.63

Taxes

KRW

Over the twelve months ended June 30, 2026, Psomagen Inc Shs Korean Depositary Receipt Repr 1 Sh recorded 7.64M in income tax expense. The company reported a pretax loss of -1.80B and 2.10B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax7.64M

Stock Price Statistics

KRW

As of the close on November 17, 2026, Psomagen Inc Shs Korean Depositary Receipt Repr 1 Sh's stock has declined approximately 28.88% over the past 52 weeks. The 50-day moving average sits at 2,962.50, while the 200-day moving average is 3,190.45.

52-Week Price Change-28.88%
50-Day Moving Average2,962.50
200-Day Moving Average3,190.45

Income Statement

KRW

Over the twelve months ended June 30, 2026, Psomagen Inc Shs Korean Depositary Receipt Repr 1 Sh generated 57.29B in revenue and converted that into 2.10B in net income, yielding earnings per share of -91.27. EBITDA reached 3.09B, while operating income came in at -817.61M.

Revenue57.29B
Gross Profit14.46B
Operating Income-817.61M
Pretax Income-1.80B
Net Income2.10B
EBITDA3.09B
EBIT-817.61M
Earnings Per Share (EPS)-91.27

Balance Sheet

KRW

As of June 30, 2026, Psomagen Inc Shs Korean Depositary Receipt Repr 1 Sh holds 16.40B in cash and equivalents against 9.85B in total debt, resulting in a net debt position of -9.35B. Total book value stands at 31.95B, with working capital of 18.25B providing operational flexibility.

Cash & Cash Equivalents16.40B
Total Debt9.85B
Net Debt-9.35B
Equity (Book Value)31.95B
Book Value Per Share1,661.12
Working Capital18.25B

Cash Flow

KRW

These figures cover the twelve months ended June 30, 2026.

Capital Expenditures-622.62M

Margins

Over the twelve months ended June 30, 2026, Psomagen Inc Shs Korean Depositary Receipt Repr 1 Sh posted a gross margin of 25.23, reflecting its pricing power and cost economics. The operating margin of -1.43 and net profit margin of 3.66 provide insight into operational efficiency.

Gross Margin25.23
Operating Margin-1.43
Pretax Margin-3.13
Profit Margin3.66
EBITDA Margin5.40

Scores

As of June 30, 2026, Psomagen Inc Shs Korean Depositary Receipt Repr 1 Sh has an Altman Z-Score of 3.78, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score3.78